Dossier assessment
Melatonin (sleep disorders) - Benefit assessment according to §35a Social Code Book V
Report documents
-
Extract of dossier assessment
Melatonin (sleep disorders) - Benefit assessment according to §35a Social Code Book V
-
Dossier assessment
Melatonin (sleep disorders) - Benefit assessment according to §35a Social Code Book V
Dossier assessment
Insomnia in children and adolescents with Autism Spectrum Disorder and/or Smith-Magenis syndrome, where sleep hygiene measures have been insufficient
Added benefit not proven due to lack of informative study data
Additional information
Federal Joint Committee (G-BA)
17 October 2024: The G-BA’s decision of 4 July 2019 was cancelled.
G-BA documents on this decision
Project details
- Project no.
- A19-04
- Commission
- Commission awarded on 11.01.2019 by the Federal Joint Committee (GBA).
- Report type
- Dossier assessment
- Status
- Commission completed
- Department/Division
- Drug Assessment
- Topic
- Digestion, metabolism and hormones
- Note
-
After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.
Connected Projects
-
Dossier assessment
Melatonin (sleep disorders in children and adolescents with autism spectrum disorder and/or Smith-Magenis syndrome) - Addendum to Commission A19-04
Status: Commission completed